Go to deals
Healthcare

NordMedica A/S has been acquired by Eurocept B.V.

The Dutch pharmaceutical company Eurocept B.V. has acquired 100% of the share capital in the Danish specialty pharmaceutical company NordMedica A/S for an undisclosed consideration.

NordMedica A/S was founded in 2003 as a privately held specialty pharmaceutical company focused on the commercialization and marketing of niche pharmaceutical products. The company holds the rights to an oncology product under the brand names Amekrin®, Amsidine® and Amsidyl® in more than 25 countries. The product is based on a chemotherapy drug for the treatment of Acute Myeloid Leukemia (AML) and Acute Lymphatic Leukemia (ALL). All other assets and liabilities together with all employees were transferred to NordMedica International before the transaction.

Eurocept is a rapidly growing company active in the pharmaceutical and homecare market in the Benelux countries. Eurocept offers products and services that answer to pharmaceutical, technological and nursing needs in medical care as well as a unique combination of medical technology and distribution in the therapeutic areas of anesthesia, oncology, pediatrics, psychiatry, immunology, ADHD and urology.

Oaklins' team in Denmark acted as financial and strategic advisor to the seller in this transaction.

Parties

Talk to the deal team

 Daniel  Sand

Daniel Sand

Partner
Copenhagen, Denmark
Oaklins Beierholm

Related deals

move UP has been acquired by Acture B.V.
Private Equity | Business Support Services | Healthcare

move UP has been acquired by Acture B.V.

move UP Gesellschaft für Gesundheitsmanagement mbH, an innovative provider of holistic corporate health management solutions, has been acquired by Acture B.V., a leader in welfare management. This acquisition represents a major step in Acture’s plans to expand into the German corporate health management sector.

Learn more
Sopharma Group has acquired two pharmaceutical products in Poland
Healthcare

Sopharma Group has acquired two pharmaceutical products in Poland

Sopharma Group has acquired Coffepirine and Kopiryna, two highly recognized medicines to treat headache. The acquisition will further expand the market presence of Sopharma Group in the Polish market and support the promising potential of the two pharmaceutical drugs.

Learn more
A group of Chilean investors has acquired Farmacias Ahumada
Consumer & Retail | Healthcare

A group of Chilean investors has acquired Farmacias Ahumada

A group of Chilean investors has acquired Farmacias Ahumada S.A. from Walgreens Boots Alliance.

Learn more